retatrutide side effects libido Effects: What Patients Should Know What is Retatrutide? Exploring The

PsA Disease Activity Improves on GLP-1s A retrospective study presented at ACR Convergence 2025, led by researchers from the University of Toronto and NYU, followed 48 patients with psoriatic arthritis who started GLP-1 receptor agonists. The findings: Significant weight loss (35% of patients lost 510% of body weight

Japans national health insurance system has covered Wegovy for weight management since February 2024, but under stringent eligibility criteria and prescribing restrictions that have kept actual patient numbers limited

Users also get access to virtual one-on-one health coaching, support groups, food and exercise trackers, and more to support their weight loss journey

Some patients view these medications as temporary tools to jumpstart weight loss, while others accept them as long-term management for a chronic condition

Tirzepatide versus Semaglutide once Weekly in Type 2 diabetes